{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:01:55Z","timestamp":1791302515601,"version":"4.1.0"},"reference-count":293,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,11,1]]},"abstract":"<jats:p>These guidelines have been developed for practitioners who insert catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home health-care settings. This report was prepared by a working group comprising members from professional organizations representing the disciplines of critical care medicine, infectious diseases, health-care infection control, surgery, anesthesiology, interventional radiology, pulmonary medicine, pediatric medicine, and nursing. The working group was led by the Society of Critical Care Medicine (SCCM), in collaboration with the Infectious Disease Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Surgical Infection Society (SIS), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), American Society of Critical Care Anesthesiologists (ASCCA), Association for Professionals in Infection Control and Epidemiology (APIC), Infusion Nurses Society (INS), Oncology Nursing Society (ONS), Society of Cardiovascular and Interventional Radiology (SCVIR), American Academy of Pediatrics (AAP), and the Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and Prevention (CDC) and is intended to replace the Guideline for Prevention of Intravascular Device-Related Infections published in 1996. These guidelines are intended to provide evidence-based recommendations for preventing catheter-related infections. Major areas of emphasis include 1) educating and training health-care providers who insert and maintain catheters; 2) using maximal sterile barrier precautions during central venous catheter insertion; 3) using a 2% chlorhexidine preparation for skin antisepsis; 4) avoiding routine replacement of central venous catheters as a strategy to prevent infection; and 5) using antiseptic\/antibiotic impregnated short-term central venous catheters if the rate of infection is high despite adherence to other strategies (ie, education and training, maximal sterile barrier precautions, and 2% chlorhexidine for skin antisepsis). These guidelines also identify performance indicators that can be used locally by health-care institutions or organizations to monitor their success in implementing these evidence-based recommendations.<\/jats:p>","DOI":"10.1542\/peds.110.5.e51","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:17:55Z","timestamp":1092442675000},"page":"e51-e51","source":"Crossref","is-referenced-by-count":267,"title":["Guidelines for the Prevention of Intravascular Catheter-Related Infections"],"prefix":"10.1542","volume":"110","author":[{"given":"Naomi P.","family":"O\u2019Grady","sequence":"first","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Alexander","sequence":"additional","affiliation":[{"name":"Infusion Nurses Society, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Patchen","family":"Dellinger","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Gerberding","sequence":"additional","affiliation":[{"name":"Office of the Director, CDC, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen O.","family":"Heard","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis G.","family":"Maki","sequence":"additional","affiliation":[{"name":"University of Wisconsin Medical School, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Masur","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita D.","family":"McCormick","sequence":"additional","affiliation":[{"name":"University of Wisconsin Hospital and Clinics, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Mermel","sequence":"additional","affiliation":[{"name":"Rhode Island Hospital and Brown University School of Medicine, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele L.","family":"Pearson","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Infectious Diseases Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam I.","family":"Raad","sequence":"additional","affiliation":[{"name":"M. D. Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Randolph","sequence":"additional","affiliation":[{"name":"The Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Cook County Hospital and Rush Medical College, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,11,1]]},"reference":[{"key":"2021121006381515900_R1","doi-asserted-by":"crossref","unstructured":"Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control.1996;24 :262\u2013 277","DOI":"10.1016\/S0196-6553(96)90058-9"},{"key":"2021121006381515900_R2","doi-asserted-by":"crossref","unstructured":"Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med.2000;132 :391\u2013 402","DOI":"10.7326\/0003-4819-132-5-200003070-00009"},{"key":"2021121006381515900_R3","doi-asserted-by":"crossref","unstructured":"CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986\u2013April 1998, issued June 1998. Am J Infect Control.1998;26 :522\u2013 533","DOI":"10.1016\/S0196-6553(98)70026-4"},{"key":"2021121006381515900_R4","doi-asserted-by":"crossref","unstructured":"Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med.1999;160 :976\u2013 981","DOI":"10.1164\/ajrccm.160.3.9808145"},{"key":"2021121006381515900_R5","doi-asserted-by":"crossref","unstructured":"Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med.2000;162 :1027\u2013 1030","DOI":"10.1164\/ajrccm.162.3.9911093"},{"key":"2021121006381515900_R6","doi-asserted-by":"crossref","unstructured":"Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol.1999;20 :396\u2013 401","DOI":"10.1086\/501639"},{"key":"2021121006381515900_R7","doi-asserted-by":"crossref","unstructured":"Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust.1994;161 :374\u2013 378","DOI":"10.5694\/j.1326-5377.1994.tb127491.x"},{"key":"2021121006381515900_R8","doi-asserted-by":"crossref","unstructured":"Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA.1994;271 :1598\u2013 1601","DOI":"10.1001\/jama.271.20.1598"},{"key":"2021121006381515900_R9","doi-asserted-by":"crossref","unstructured":"Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg.2001;136 :229\u2013 234","DOI":"10.1001\/archsurg.136.2.229"},{"key":"2021121006381515900_R10","doi-asserted-by":"crossref","unstructured":"Mermel LA. Correction: catheter related bloodstream-infections. Ann Intern Med.2000;133 :395","DOI":"10.7326\/0003-4819-133-5-200009050-00026"},{"key":"2021121006381515900_R11","unstructured":"Kluger DM, Maki DG. The relative risk of intravascular device related bloodstream infections in adults [abstract]. In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: American Society for Microbiology; 1999:514"},{"key":"2021121006381515900_R12","doi-asserted-by":"crossref","unstructured":"CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990\u2013May 1999, issued June 1999. Am J Infect Control.1999;27 :520\u2013 532","DOI":"10.1016\/S0196-6553(99)70031-3"},{"key":"2021121006381515900_R13","unstructured":"Joint Commission on the Accreditation of Healthcare Organizations. Accreditation manual for hospitals. In: Joint Commission on the Accreditation of Healthcare Organizations, ed. Chicago, IL: Joint Commission on the Accreditation of Healthcare Organizations; 1994:121\u2013140"},{"key":"2021121006381515900_R14","doi-asserted-by":"crossref","unstructured":"CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992\u2013June 2001, issued August 2001. Am J Infect Control.2001;6 :404\u2013 421","DOI":"10.1067\/mic.2001.119952"},{"key":"2021121006381515900_R15","doi-asserted-by":"crossref","unstructured":"Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med.1991;91(suppl) :S72\u2013 S75","DOI":"10.1016\/0002-9343(91)90346-Y"},{"key":"2021121006381515900_R16","doi-asserted-by":"crossref","unstructured":"Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980\u20131989. National Nosocomial Infections Surveillance System. Am J Med.1991;91(suppl) :S86\u2013 S89","DOI":"10.1016\/0002-9343(91)90349-3"},{"key":"2021121006381515900_R17","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis.1998;31 :327\u2013 332","DOI":"10.1016\/S0732-8893(97)00240-X"},{"key":"2021121006381515900_R18","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis.1998;30 :121\u2013 129","DOI":"10.1016\/S0732-8893(97)00192-2"},{"key":"2021121006381515900_R19","doi-asserted-by":"crossref","unstructured":"Nguyen MH, Peacock JE Jr, Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med.1996;100 :617\u2013 623","DOI":"10.1016\/S0002-9343(95)00010-0"},{"key":"2021121006381515900_R20","doi-asserted-by":"crossref","unstructured":"Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med.1999;20 :303\u2013 316","DOI":"10.1016\/S0272-5231(05)70143-X"},{"key":"2021121006381515900_R21","doi-asserted-by":"crossref","unstructured":"Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med.1977;296 :1305\u2013 1309","DOI":"10.1056\/NEJM197706092962301"},{"key":"2021121006381515900_R22","doi-asserted-by":"crossref","unstructured":"Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med.1991;91(suppl) :S197\u2013 S205","DOI":"10.1016\/0002-9343(91)90369-9"},{"key":"2021121006381515900_R23","doi-asserted-by":"crossref","unstructured":"Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. Parenter Enteral Nutr.1985;9 :322\u2013 325","DOI":"10.1177\/0148607185009003322"},{"key":"2021121006381515900_R24","doi-asserted-by":"crossref","unstructured":"Linares J, Sitges-Serra A, Garau J, Perez JL, Martin R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol.1985;21 :357\u2013 360","DOI":"10.1128\/jcm.21.3.357-360.1985"},{"key":"2021121006381515900_R25","doi-asserted-by":"crossref","unstructured":"Raad II, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis.1993;168 :400\u2013 407","DOI":"10.1093\/infdis\/168.2.400"},{"key":"2021121006381515900_R26","unstructured":"Maki DG. Infections associated with intravascular lines. In: Remington JS, ed. Current Clinical Topics in Infectious Diseases. New York, NY: McGraw-Hill; 1982:309\u2013363"},{"key":"2021121006381515900_R27","doi-asserted-by":"crossref","unstructured":"Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol.1983;18 :1061\u2013 1063","DOI":"10.1128\/jcm.18.5.1061-1063.1983"},{"key":"2021121006381515900_R28","unstructured":"Ashkenazi S, Weiss E, Drucker MM, Bodey GP. Bacterial adherence to intravenous catheters and needles and its influence by cannula type and bacterial surface hydrophobicity. J Lab Clin Med.1986;107 :136\u2013 140"},{"key":"2021121006381515900_R29","unstructured":"Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices. IV. Scanning electron microscopy of intravenous catheters invaded by yeasts. Zentralbl Bakteriol Mikrobiol Hyg [B].1981;173 :419\u2013 424"},{"key":"2021121006381515900_R30","unstructured":"Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices. I. Microtopographical characteristics of intravenous catheters as detected by scanning electron microscopy. Zentralbl Bakteriol Mikrobiol Hyg [B].1981;173 :285\u2013 292"},{"key":"2021121006381515900_R31","doi-asserted-by":"crossref","unstructured":"Nachnani GH, Lessin LS, Motomiya T, Jensen WN, Bodey GP. Scanning electron microscopy of thrombogenesis on vascular catheter surfaces. N Engl J Med.1972;286 :139\u2013 140","DOI":"10.1056\/NEJM197201202860306"},{"key":"2021121006381515900_R32","doi-asserted-by":"crossref","unstructured":"Stillman RM, Soliman F, Garcia L, Sawyer PN. Etiology of catheter-associated sepsis. Correlation with thrombogenicity. Arch Surg.1977;112 :1497\u2013 1499","DOI":"10.1001\/archsurg.1977.01370120087011"},{"key":"2021121006381515900_R33","doi-asserted-by":"crossref","unstructured":"Herrmann M, Lai QJ, Albrecht RM, Mosher DF, Proctor RA. Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen\/fibrin and platelet integrins. J Infect Dis.1993;167 :312\u2013 322","DOI":"10.1093\/infdis\/167.2.312"},{"key":"2021121006381515900_R34","doi-asserted-by":"crossref","unstructured":"Herrmann M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun.1991;59 :279\u2013 288","DOI":"10.1128\/iai.59.1.279-288.1991"},{"key":"2021121006381515900_R35","doi-asserted-by":"crossref","unstructured":"Ludwicka A, Uhlenbruck G, Peters G, et al. Investigation on extracellular slime substance produced by Staphylococcus epidermidis. Zentralbl Bakteriol Mikrobiol Hyg.1984;258 :256\u2013 267","DOI":"10.1016\/S0176-6724(84)80043-7"},{"key":"2021121006381515900_R36","doi-asserted-by":"crossref","unstructured":"Gray ED, Peters G, Verstegen M, Regelmann WE. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet.1984;1 :365\u2013 367","DOI":"10.1016\/S0140-6736(84)90413-6"},{"key":"2021121006381515900_R37","doi-asserted-by":"crossref","unstructured":"Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis.1990;161 :37\u2013 40","DOI":"10.1093\/infdis\/161.1.37"},{"key":"2021121006381515900_R38","doi-asserted-by":"crossref","unstructured":"Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol.1994;32 :452\u2013 456","DOI":"10.1128\/jcm.32.2.452-456.1994"},{"key":"2021121006381515900_R39","doi-asserted-by":"crossref","unstructured":"Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med.2000;132 :641\u2013 648","DOI":"10.7326\/0003-4819-132-8-200004180-00007"},{"key":"2021121006381515900_R40","doi-asserted-by":"crossref","unstructured":"Ryan JA Jr, Abel RM, Abbott WM, et al. Catheter complications in total parenteral nutrition: a prospective study of 200 consecutive patients. N Engl J Med.1974;290 :757\u2013 761","DOI":"10.1056\/NEJM197404042901401"},{"key":"2021121006381515900_R41","doi-asserted-by":"crossref","unstructured":"Sanders RA, Sheldon GF. Septic complications of total parenteral nutrition: a five year experience. Am J Surg.1976;132 :214\u2013 220","DOI":"10.1016\/0002-9610(76)90050-7"},{"key":"2021121006381515900_R42","doi-asserted-by":"crossref","unstructured":"Murphy LM, Lipman TO. Central venous catheter care in parenteral nutrition: a review. Parenter Enteral Nutr.1987;11 :190\u2013 201","DOI":"10.1177\/014860718701100220"},{"key":"2021121006381515900_R43","doi-asserted-by":"crossref","unstructured":"Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet.2000;355 :1864\u2013 1868","DOI":"10.1016\/S0140-6736(00)02291-1"},{"key":"2021121006381515900_R44","doi-asserted-by":"crossref","unstructured":"Armstrong CW, Mayhall CG, Miller KB, et al. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis.1986;154 :808\u2013 816","DOI":"10.1093\/infdis\/154.5.808"},{"key":"2021121006381515900_R45","doi-asserted-by":"crossref","unstructured":"Nehme AE. Nutritional support of the hospitalized patient: the team concept. JAMA.1980;243 :1906\u2013 1908","DOI":"10.1001\/jama.243.19.1906"},{"key":"2021121006381515900_R46","doi-asserted-by":"crossref","unstructured":"Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med.1998;158 :473\u2013 477","DOI":"10.1001\/archinte.158.5.473"},{"key":"2021121006381515900_R47","unstructured":"Tomford JW, Hershey CO. The IV therapy team: impact on patient care and costs of hospitalization. NITA.1985;8 :387\u2013 389"},{"key":"2021121006381515900_R48","doi-asserted-by":"crossref","unstructured":"Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol.1996;17 :150\u2013 158","DOI":"10.1086\/647262"},{"key":"2021121006381515900_R49","doi-asserted-by":"crossref","unstructured":"Bansmer G, Keith D, Tesluk H. Complications following use of indwelling catheters of inferior vena cava. JAMA.1958;167 :1606\u2013 1611","DOI":"10.1001\/jama.1958.02990300032007"},{"key":"2021121006381515900_R50","doi-asserted-by":"crossref","unstructured":"Crane C. Venous interruption of septic thrombophlebitis. N Engl J Med.1960;262 :947\u2013 951","DOI":"10.1056\/NEJM196005122621901"},{"key":"2021121006381515900_R51","doi-asserted-by":"crossref","unstructured":"Indar R. The dangers of indwelling polyethelene cannulae in deep veins. Lancet.1959;1 :284\u2013 286","DOI":"10.1016\/S0140-6736(59)90207-7"},{"key":"2021121006381515900_R52","unstructured":"Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Hospital Infections. 4th ed. Philadelphia, PA: Lippencott-Raven; 1998:689\u2013724"},{"key":"2021121006381515900_R53","doi-asserted-by":"crossref","unstructured":"Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med.1998;158 :81\u2013 87","DOI":"10.1001\/archinte.158.1.81"},{"key":"2021121006381515900_R54","doi-asserted-by":"crossref","unstructured":"Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol.1990;28 :2520\u2013 2525","DOI":"10.1128\/jcm.28.11.2520-2525.1990"},{"key":"2021121006381515900_R55","doi-asserted-by":"crossref","unstructured":"Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol.1998;19 :842\u2013 845","DOI":"10.1086\/647742"},{"key":"2021121006381515900_R56","doi-asserted-by":"crossref","unstructured":"Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest.2000;117 :178\u2013 183","DOI":"10.1378\/chest.117.1.178"},{"key":"2021121006381515900_R57","doi-asserted-by":"crossref","unstructured":"Mian NZ, Bayly R, Schreck DM, Besserman EB, Richmand D. Incidence of deep venous thrombosis associated with femoral venous catheterization. Acad Emerg Med.1997;4 :1118\u2013 1121","DOI":"10.1111\/j.1553-2712.1997.tb03693.x"},{"key":"2021121006381515900_R58","doi-asserted-by":"crossref","unstructured":"Durbec O, Viviand X, Potie F, Vialet R, Albanese J, Martin C. A prospective evaluation of the use of femoral venous catheters in critically ill adults. Crit Care Med.1997;25 :1986\u2013 1989","DOI":"10.1097\/00003246-199712000-00014"},{"key":"2021121006381515900_R59","doi-asserted-by":"crossref","unstructured":"Trottier SJ, Veremakis C, O\u2019Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Crit Care Med.1995;23 :52\u2013 59","DOI":"10.1097\/00003246-199501000-00011"},{"key":"2021121006381515900_R60","doi-asserted-by":"crossref","unstructured":"Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA.2001;286 :700\u2013 707","DOI":"10.1001\/jama.286.6.700"},{"key":"2021121006381515900_R61","doi-asserted-by":"crossref","unstructured":"Venkataraman ST, Thompson AE, Orr RA. Femoral vascular catheterization in critically ill infants and children. Clin Pediatr.1997;36 :311\u2013 319","DOI":"10.1177\/000992289703600601"},{"key":"2021121006381515900_R62","doi-asserted-by":"crossref","unstructured":"Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous femoral venous catheterizations: a prospective study of complications. J Pediatr.1989;114 :411\u2013 415","DOI":"10.1016\/S0022-3476(89)80559-1"},{"key":"2021121006381515900_R63","doi-asserted-by":"crossref","unstructured":"Goldstein AM, Weber JM, Sheridan RL. Femoral venous access is safe in burned children: an analysis of 224 catheters. J Pediatr.1997;130 :442\u2013 446","DOI":"10.1016\/S0022-3476(97)70208-7"},{"key":"2021121006381515900_R64","doi-asserted-by":"crossref","unstructured":"Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med.1996;24 :2053\u2013 2058","DOI":"10.1097\/00003246-199612000-00020"},{"key":"2021121006381515900_R65","doi-asserted-by":"crossref","unstructured":"Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA.1987;258 :2396\u2013 2403","DOI":"10.1001\/jama.258.17.2396"},{"key":"2021121006381515900_R66","doi-asserted-by":"crossref","unstructured":"Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med.1991;114 :845\u2013 854","DOI":"10.7326\/0003-4819-114-10-845"},{"key":"2021121006381515900_R67","doi-asserted-by":"crossref","unstructured":"Band JD, Maki DG. Steel needles used for intravenous therapy: morbidity in patients with hematologic malignancy. Arch Intern Med.1980;140 :31\u2013 34","DOI":"10.1001\/archinte.140.1.31"},{"key":"2021121006381515900_R68","doi-asserted-by":"crossref","unstructured":"Tully JL, Friedland GH, Baldini LM, Goldmann DA. Complications of intravenous therapy with steel needles and Teflon catheters: a comparative study. Am J Med.1981;70 :702\u2013 706","DOI":"10.1016\/0002-9343(81)90600-8"},{"key":"2021121006381515900_R69","doi-asserted-by":"crossref","unstructured":"Pittet D, Hugonnet S, Harbath S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet.2000;356 :1307\u2013 1309","DOI":"10.1016\/S0140-6736(00)02814-2"},{"key":"2021121006381515900_R70","doi-asserted-by":"crossref","unstructured":"Larson EL, Rackoff WR, Weiman M, et al. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control.1995;23 :251\u2013 269","DOI":"10.1016\/0196-6553(95)90070-5"},{"key":"2021121006381515900_R71","doi-asserted-by":"crossref","unstructured":"Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol.1994;15 :231\u2013 238","DOI":"10.1086\/646902"},{"key":"2021121006381515900_R72","doi-asserted-by":"crossref","unstructured":"Clemence MA, Walker D, Farr BM. Central venous catheter practices: results of a survey. Am J Infect Control.1995;23 :5\u2013 12","DOI":"10.1016\/0196-6553(95)90002-0"},{"key":"2021121006381515900_R73","doi-asserted-by":"crossref","unstructured":"Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet.1991;338 :339\u2013 343","DOI":"10.1016\/0140-6736(91)90479-9"},{"key":"2021121006381515900_R74","doi-asserted-by":"crossref","unstructured":"Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis.2000;31 :1001\u2013 1007","DOI":"10.1086\/318145"},{"key":"2021121006381515900_R75","doi-asserted-by":"crossref","unstructured":"Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J.1995;14 :510\u2013 516","DOI":"10.1097\/00006454-199506000-00008"},{"key":"2021121006381515900_R76","doi-asserted-by":"crossref","unstructured":"Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing: a meta-analysis of the infection risks. JAMA.1992;267 :2072\u2013 2076","DOI":"10.1001\/jama.267.15.2072"},{"key":"2021121006381515900_R77","unstructured":"Maki DG, Mermel LA, Klugar D, et al. The efficacy of a chlorhexidine impregnated sponge (Biopatch) for the prevention of intravascular catheter-related infection- a prospective randomized controlled multicenter study [abstract]. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, Canada: American Society for Microbiology, 2000"},{"key":"2021121006381515900_R78","doi-asserted-by":"crossref","unstructured":"Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol.2002;13 :77\u2013 81","DOI":"10.1016\/S1051-0443(07)60012-8"},{"key":"2021121006381515900_R79","doi-asserted-by":"crossref","unstructured":"Rusho WJ, Bair JN. Effect of filtration on complications of postoperative intravenous therapy. Am J Hosp Pharm.1979;36 :1355\u2013 1356","DOI":"10.1093\/ajhp\/36.10.1355"},{"key":"2021121006381515900_R80","unstructured":"Maddox RR, John JF Jr, Brown LL, Smith CE. Effect of inline filtration on postinfusion phlebitis. Clin Pharm.1983;2 :58\u2013 61"},{"key":"2021121006381515900_R81","doi-asserted-by":"crossref","unstructured":"Turco SJ, Davis NM. Particulate matter in intravenous infusion fluids\u2014phase 3. Am J Hosp Pharm.1973;30 :611\u2013 613","DOI":"10.1093\/ajhp\/30.7.611"},{"key":"2021121006381515900_R82","doi-asserted-by":"crossref","unstructured":"Baumgartner TG, Schmidt GL, Thakker KM, et al. Bacterial endotoxin retention by inline intravenous filters. Am J Hosp Pharm.1986;43 :681\u2013 684","DOI":"10.1093\/ajhp\/43.3.681"},{"key":"2021121006381515900_R83","doi-asserted-by":"crossref","unstructured":"Butler DL, Munson JM, DeLuca PP. Effect of inline filtration on the potency of low-dose drugs. Am J Hosp Pharm.1980;37 :935\u2013 941","DOI":"10.1093\/ajhp\/37.7.935"},{"key":"2021121006381515900_R84","doi-asserted-by":"crossref","unstructured":"Raad II, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med.1997;127 :267\u2013 274","DOI":"10.7326\/0003-4819-127-4-199708150-00002"},{"key":"2021121006381515900_R85","doi-asserted-by":"crossref","unstructured":"Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA.1999;281 :261\u2013 267","DOI":"10.1001\/jama.281.3.261"},{"key":"2021121006381515900_R86","doi-asserted-by":"crossref","unstructured":"Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med.1997;127 :257\u2013 266","DOI":"10.7326\/0003-4819-127-4-199708150-00001"},{"key":"2021121006381515900_R87","doi-asserted-by":"crossref","unstructured":"Raad II, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis.1996;173 :418\u2013 424","DOI":"10.1093\/infdis\/173.2.418"},{"key":"2021121006381515900_R88","doi-asserted-by":"crossref","unstructured":"Bassetti S, Hu J, D\u2019Agostino RB Jr, Sherertz RJ. Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother.2001;45 :1535\u2013 1538","DOI":"10.1128\/AAC.45.5.1535-1538.2001"},{"key":"2021121006381515900_R89","doi-asserted-by":"crossref","unstructured":"Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology.1997;87 :1242\u2013 1244","DOI":"10.1097\/00000542-199711000-00031"},{"key":"2021121006381515900_R90","doi-asserted-by":"crossref","unstructured":"Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA.1999;282 :554\u2013 560","DOI":"10.1001\/jama.282.6.554"},{"key":"2021121006381515900_R91","doi-asserted-by":"crossref","unstructured":"Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med.1999;340 :1\u2013 8","DOI":"10.1056\/NEJM199901073400101"},{"key":"2021121006381515900_R92","unstructured":"Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000"},{"key":"2021121006381515900_R93","doi-asserted-by":"crossref","unstructured":"Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med.1988;85 :307\u2013 314","DOI":"10.1016\/0002-9343(88)90579-7"},{"key":"2021121006381515900_R94","doi-asserted-by":"crossref","unstructured":"Dahlberg PJ, Agger WA, Singer JR, et al. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol.1995;16 :506\u2013 511","DOI":"10.1086\/647169"},{"key":"2021121006381515900_R95","doi-asserted-by":"crossref","unstructured":"Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg.1993;218 :206\u2013 210","DOI":"10.1097\/00000658-199308000-00014"},{"key":"2021121006381515900_R96","unstructured":"Bonawitz SC, Hammell EJ, Kirkpatrick JR. Prevention of central venous catheter sepsis: a prospective randomized trial. Am Surg.1991;57 :618\u2013 623"},{"key":"2021121006381515900_R97","doi-asserted-by":"crossref","unstructured":"McKee R, Dunsmuir R, Whitby M, Garden OJ. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect.1985;6 :419\u2013 425","DOI":"10.1016\/0195-6701(85)90059-3"},{"key":"2021121006381515900_R98","doi-asserted-by":"crossref","unstructured":"Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect.1990;15 :95\u2013 102","DOI":"10.1016\/0195-6701(90)90025-J"},{"key":"2021121006381515900_R99","doi-asserted-by":"crossref","unstructured":"Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer.1997;5 :485\u2013 458","DOI":"10.1007\/s005200050117"},{"key":"2021121006381515900_R100","doi-asserted-by":"crossref","unstructured":"Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of gram-positive sepsis in neonates weighing less than 1500 g. J Pediatr.1994;125 :253\u2013 258","DOI":"10.1016\/S0022-3476(94)70207-1"},{"key":"2021121006381515900_R101","doi-asserted-by":"crossref","unstructured":"Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr.1994;125 :259\u2013 263","DOI":"10.1016\/S0022-3476(94)70208-X"},{"key":"2021121006381515900_R102","unstructured":"CDC. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep.1995;44(No. RR-12) :1\u2013 13"},{"key":"2021121006381515900_R103","doi-asserted-by":"crossref","unstructured":"Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int.1991;40 :934\u2013 938","DOI":"10.1038\/ki.1991.297"},{"key":"2021121006381515900_R104","doi-asserted-by":"crossref","unstructured":"Casewell MW. The nose: an underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect.1998;40(suppl) :S3\u2013 S11","DOI":"10.1016\/S0195-6701(98)90199-2"},{"key":"2021121006381515900_R105","doi-asserted-by":"crossref","unstructured":"Hill RL, Fisher AP, Ware RJ, Wilson S, Casewell MW. Mupirocin for the reduction of colonization of internal jugular cannulae\u2014a randomized controlled trial. J Hosp Infect.1990;15 :311\u2013 321","DOI":"10.1016\/0195-6701(90)90088-6"},{"key":"2021121006381515900_R106","doi-asserted-by":"crossref","unstructured":"Sesso R, Barbosa D, Leme IL, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol.1998;9 :1085\u2013 1092","DOI":"10.1681\/ASN.V961085"},{"key":"2021121006381515900_R107","doi-asserted-by":"crossref","unstructured":"Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect.1995;31 :189\u2013 193","DOI":"10.1016\/0195-6701(95)90065-9"},{"key":"2021121006381515900_R108","doi-asserted-by":"crossref","unstructured":"Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol.1996;17 :811\u2013 813","DOI":"10.1086\/647242"},{"key":"2021121006381515900_R109","doi-asserted-by":"crossref","unstructured":"Rao SP, Oreopoulos DG. Unusual complications of a polyurethane PD catheter. Perit Dial Int.1997;17 :410\u2013 412","DOI":"10.1177\/089686089701700427"},{"key":"2021121006381515900_R110","doi-asserted-by":"crossref","unstructured":"Riu S, Ruiz CG, Martinez-Vea A, Peralta C, Oliver JA. Spontaneous rupture of polyurethane peritoneal catheter: a possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant.1998;13 :1870\u2013 1871","DOI":"10.1093\/ndt\/13.7.1870"},{"key":"2021121006381515900_R111","doi-asserted-by":"crossref","unstructured":"von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med.2001;344 :11\u2013 16","DOI":"10.1056\/NEJM200101043440102"},{"key":"2021121006381515900_R112","doi-asserted-by":"crossref","unstructured":"Zinner SH, Denny-Brown BC, Braun P, Burke JP, Toala P, Kass EH. Risk of infection with intravenous indwelling catheters: effect of application of antibiotic ointment. J Infect Dis.1969;120 :616\u2013 619","DOI":"10.1093\/infdis\/120.5.616"},{"key":"2021121006381515900_R113","doi-asserted-by":"crossref","unstructured":"Norden CW. Application of antibiotic ointment to the site of venous catheterization\u2014a controlled trial. J Infect Dis.1969;120 :611\u2013 615","DOI":"10.1093\/infdis\/120.5.611"},{"key":"2021121006381515900_R114","doi-asserted-by":"crossref","unstructured":"Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med.1981;70 :739\u2013 744","DOI":"10.1016\/0002-9343(81)90605-7"},{"key":"2021121006381515900_R115","doi-asserted-by":"crossref","unstructured":"Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin\/ciprofloxacin\/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol.2000;18 :1269\u2013 1278","DOI":"10.1200\/JCO.2000.18.6.1269"},{"key":"2021121006381515900_R116","doi-asserted-by":"crossref","unstructured":"Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother.1999;43 :2200\u2013 2204","DOI":"10.1128\/AAC.43.9.2200"},{"key":"2021121006381515900_R117","doi-asserted-by":"crossref","unstructured":"Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol.1990;8 :1591\u2013 1597","DOI":"10.1200\/JCO.1990.8.9.1591"},{"key":"2021121006381515900_R118","doi-asserted-by":"crossref","unstructured":"Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr.1995;127 :147\u2013 151","DOI":"10.1016\/S0022-3476(95)70276-8"},{"key":"2021121006381515900_R119","doi-asserted-by":"crossref","unstructured":"Raad II, Buzaid A, Rhyne J, et al. Minocycline and ethylene-diaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis.1997;25 :149\u2013 151","DOI":"10.1086\/514518"},{"key":"2021121006381515900_R120","doi-asserted-by":"crossref","unstructured":"Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA.1994;271 :1014\u2013 1016","DOI":"10.1001\/jama.271.13.1014"},{"key":"2021121006381515900_R121","doi-asserted-by":"crossref","unstructured":"Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risk factors, and relationship with catheter-related sepsis. Chest.1998;114 :207\u2013 213","DOI":"10.1378\/chest.114.1.207"},{"key":"2021121006381515900_R122","doi-asserted-by":"crossref","unstructured":"Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest.1998;113 :165\u2013 171","DOI":"10.1378\/chest.113.1.165"},{"key":"2021121006381515900_R123","doi-asserted-by":"crossref","unstructured":"Mermel LA, Stolz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis.1993;167 :920\u2013 924","DOI":"10.1093\/infdis\/167.4.920"},{"key":"2021121006381515900_R124","doi-asserted-by":"crossref","unstructured":"Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med.2000;26 :967\u2013 972","DOI":"10.1007\/s001340051289"},{"key":"2021121006381515900_R125","doi-asserted-by":"crossref","unstructured":"Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med.1990;112 :423\u2013 428","DOI":"10.7326\/0003-4819-76-3-112-6-423"},{"key":"2021121006381515900_R126","doi-asserted-by":"crossref","unstructured":"Boraks P, Seale J, Price J, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol.1998;101 :483\u2013 486","DOI":"10.1046\/j.1365-2141.1998.00732.x"},{"key":"2021121006381515900_R127","doi-asserted-by":"crossref","unstructured":"Collin J, Collin C. Infusion thrombophlebitis. Lancet.1975;2 :458","DOI":"10.1016\/S0140-6736(75)90875-2"},{"key":"2021121006381515900_R128","doi-asserted-by":"crossref","unstructured":"Lai KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. Am J Infect Control.1998;26 :66\u2013 70","DOI":"10.1016\/S0196-6553(98)70063-X"},{"key":"2021121006381515900_R129","unstructured":"Fontaine PJ. Performance of a new softening expanding midline catheter in home intravenous therapy patients. J Intraven Nurs.1991;14 :91\u2013 99"},{"key":"2021121006381515900_R130","doi-asserted-by":"crossref","unstructured":"Harwood IR, Greene LM, Kozakowski-Koch JA, Rasor JS. New peripherally inserted midline catheter: a better alternative for intravenous antibiotic therapy in patients with cystic fibrosis. Pediatr Pulmonol.1992;12 :233\u2013 239","DOI":"10.1002\/ppul.1950120407"},{"key":"2021121006381515900_R131","doi-asserted-by":"crossref","unstructured":"Mermel LA, Parenteau S, Tow SM. The risk of midline catheterization in hospitalized patients. A prospective study. Ann Intern Med.1995;123 :841\u2013 844","DOI":"10.7326\/0003-4819-123-11-199512010-00005"},{"key":"2021121006381515900_R132","doi-asserted-by":"crossref","unstructured":"Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med.1990;18 :1073\u2013 1079","DOI":"10.1097\/00003246-199010000-00005"},{"key":"2021121006381515900_R133","doi-asserted-by":"crossref","unstructured":"Uldall PR, Merchant N, Woods F, Yarworski U, Vas S. Changing subclavian haemodialysis cannulas to reduce infection. Lancet.1981;1 :1373","DOI":"10.1016\/S0140-6736(81)92553-8"},{"key":"2021121006381515900_R134","doi-asserted-by":"crossref","unstructured":"Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med.1997;25 :1417\u2013 1424","DOI":"10.1097\/00003246-199708000-00033"},{"key":"2021121006381515900_R135","doi-asserted-by":"crossref","unstructured":"Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med.1992;327 :1062\u2013 1068","DOI":"10.1056\/NEJM199210083271505"},{"key":"2021121006381515900_R136","doi-asserted-by":"crossref","unstructured":"Robinson D, Suhocki P, Schwab SJ. Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int.1998;53 :1792\u2013 1794","DOI":"10.1046\/j.1523-1755.1998.00954.x"},{"key":"2021121006381515900_R137","doi-asserted-by":"crossref","unstructured":"Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol.1999;10 :1045\u2013 1049","DOI":"10.1681\/ASN.V1051045"},{"key":"2021121006381515900_R138","doi-asserted-by":"crossref","unstructured":"Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis.1999;34 :1114\u2013 1124","DOI":"10.1016\/S0272-6386(99)70018-1"},{"key":"2021121006381515900_R139","doi-asserted-by":"crossref","unstructured":"Duszak R Jr, Haskal ZJ, Thomas-Hawkins C, et al. Replacement of failing tunneled hemodialysis catheters through pre-existing subcutaneous tunnels: a comparison of catheter function and infection rates for de novo placements and over-the-wire exchanges. J Vasc Interv Radiol.1998;9 :321\u2013 327","DOI":"10.1016\/S1051-0443(98)70275-1"},{"key":"2021121006381515900_R140","doi-asserted-by":"crossref","unstructured":"Jaar BG, Hermann JA, Furth SL, Briggs W, Powe NR. Septicemia in diabetic hemodialysis patients: comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients. Am J Kidney Dis.2000;35 :282\u2013 292","DOI":"10.1016\/S0272-6386(00)70338-6"},{"key":"2021121006381515900_R141","doi-asserted-by":"crossref","unstructured":"Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int.1999;55 :1081\u2013 1090","DOI":"10.1046\/j.1523-1755.1999.0550031081.x"},{"key":"2021121006381515900_R142","doi-asserted-by":"crossref","unstructured":"Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol.1998;9 :869\u2013 976","DOI":"10.1681\/ASN.V95869"},{"key":"2021121006381515900_R143","doi-asserted-by":"crossref","unstructured":"Tokars JI, Miller ER, Alter MJ, et al. National surveillance of dialysis-associated diseases in the United States, 1997. Semin Dial.2000;13 :75\u2013 85","DOI":"10.1046\/j.1525-139x.2000.00026.x"},{"key":"2021121006381515900_R144","doi-asserted-by":"crossref","unstructured":"Foundation NK. III. NKF-K\/DOQI Clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis.2001;37(suppl) :S137\u2013 S181","DOI":"10.1016\/S0272-6386(01)70007-8"},{"key":"2021121006381515900_R145","doi-asserted-by":"crossref","unstructured":"Mermel LA. Intravascular catheters impregnated with benzalkonium chloride. J Antimicrob Chemother.1993;32 :905\u2013 906","DOI":"10.1093\/jac\/32.6.905-a"},{"key":"2021121006381515900_R146","doi-asserted-by":"crossref","unstructured":"Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med.1994;22 :1729\u2013 1737","DOI":"10.1097\/00003246-199422110-00006"},{"key":"2021121006381515900_R147","doi-asserted-by":"crossref","unstructured":"Raad II, Umphrey J, Khan A, Truett LJ, Bodey GP. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect.1993;23 :17\u2013 26","DOI":"10.1016\/0195-6701(93)90126-K"},{"key":"2021121006381515900_R148","doi-asserted-by":"crossref","unstructured":"Cohen Y, Fosse JP, Karoubi P, et al. The \u201chands-off\u201d catheter and the prevention of systemic infections associated with pulmonary artery catheter: a prospective study. Am J Respir Crit Care Med.1998;157 :284\u2013 287","DOI":"10.1164\/ajrccm.157.1.97-03067"},{"key":"2021121006381515900_R149","doi-asserted-by":"crossref","unstructured":"Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control.1985;6 :367\u2013 370","DOI":"10.1017\/S0195941700063335"},{"key":"2021121006381515900_R150","doi-asserted-by":"crossref","unstructured":"Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals: 72 hours is safe and cost-effective. JAMA.1987;258 :1777\u2013 1781","DOI":"10.1001\/jama.258.13.1777"},{"key":"2021121006381515900_R151","doi-asserted-by":"crossref","unstructured":"Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control.1987;8 :113\u2013 116","DOI":"10.1017\/S019594170006728X"},{"key":"2021121006381515900_R152","doi-asserted-by":"crossref","unstructured":"Hanna HA, Raad II. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol.2001;22 :165\u2013 166","DOI":"10.1086\/501885"},{"key":"2021121006381515900_R153","doi-asserted-by":"crossref","unstructured":"Raad II, Hanna HA, Awad A, et al. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol.2001;22 :136\u2013 139","DOI":"10.1086\/501879"},{"key":"2021121006381515900_R154","doi-asserted-by":"crossref","unstructured":"Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J.2001;20 :1119\u2013 1124","DOI":"10.1097\/00006454-200112000-00005"},{"key":"2021121006381515900_R155","doi-asserted-by":"crossref","unstructured":"Avila-Figueroa C, Goldmann DA, Richardson DK, Gray JE, Ferrari A, Freeman J. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J.1998;17 :10\u2013 17","DOI":"10.1097\/00006454-199801000-00004"},{"key":"2021121006381515900_R156","doi-asserted-by":"crossref","unstructured":"Crocker KS, Noga R, Filibeck DJ, Krey SH, Markovic M, Steffee WP. Microbial growth comparisons of five commercial parenteral lipid emulsions. J Parenter Enteral Nutr.1984;8 :391\u2013 395","DOI":"10.1177\/0148607184008004391"},{"key":"2021121006381515900_R157","doi-asserted-by":"crossref","unstructured":"Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol.1984;19 :17\u2013 20","DOI":"10.1128\/jcm.19.1.17-20.1984"},{"key":"2021121006381515900_R158","doi-asserted-by":"crossref","unstructured":"Melly MA, Meng HC, Schaffner W. Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg.1975;110 :1479\u2013 1481","DOI":"10.1001\/archsurg.1975.01360180049010"},{"key":"2021121006381515900_R159","doi-asserted-by":"crossref","unstructured":"Inoue Y, Nezu R, Matsuda H, et al. Prevention of catheter-related sepsis during parenteral nutrition: effect of a new connection device. J Parenter Enteral Nutr.1992;16 :581\u2013 585","DOI":"10.1177\/0148607192016006581"},{"key":"2021121006381515900_R160","doi-asserted-by":"crossref","unstructured":"Arduino MJ, Bland LA, Danzig LE, McAllister SK, Aguero SM. Microbiologic evaluation of needleless and needle-access devices. Am J Infect Control.1997;25 :377\u2013 380","DOI":"10.1016\/S0196-6553(97)90081-X"},{"key":"2021121006381515900_R161","doi-asserted-by":"crossref","unstructured":"Brown JD, Moss HA, Elliott TS. The potential for catheter microbial contamination from a needleless connector. J Hosp Infect.1997;36 :181\u2013 189","DOI":"10.1016\/S0195-6701(97)90193-6"},{"key":"2021121006381515900_R162","doi-asserted-by":"crossref","unstructured":"Cookson ST, Ihrig M, O\u2019Mara EM, et al. Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol.1998;19 :23\u2013 27","DOI":"10.1086\/647702"},{"key":"2021121006381515900_R163","doi-asserted-by":"crossref","unstructured":"Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis.1999;179 :442\u2013 448","DOI":"10.1086\/314592"},{"key":"2021121006381515900_R164","doi-asserted-by":"crossref","unstructured":"Luebke MA, Arduino MJ, Duda DL, et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control.1998;26 :437\u2013 441","DOI":"10.1016\/S0196-6553(98)70042-2"},{"key":"2021121006381515900_R165","doi-asserted-by":"crossref","unstructured":"McDonald LC, Banerjee SN, Jarvis WR. Line-associated bloodstream infections in pediatric intensive-care-unit patients associated with a needleless device and intermittent intravenous therapy. Infect Control Hosp Epidemiol.1998;19 :772\u2013 777","DOI":"10.1086\/647722"},{"key":"2021121006381515900_R166","doi-asserted-by":"crossref","unstructured":"Mendelson MH, Short LJ, Schechter CB, et al. Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes. Infect Control Hosp Epidemiol.1998;19 :401\u2013 406","DOI":"10.1086\/647839"},{"key":"2021121006381515900_R167","doi-asserted-by":"crossref","unstructured":"Seymour VM, Dhallu TS, Moss HA, Tebbs SE, Elliot TS. A prospective clinical study to investigate the microbial contamination of a needleless connector. J Hosp Infect.2000;45 :165\u2013 168","DOI":"10.1053\/jhin.2000.0726"},{"key":"2021121006381515900_R168","doi-asserted-by":"crossref","unstructured":"Longfield RN, Smith LP, Longfield JN, Coberly J, Cruess D. Multiple-dose vials: persistence of bacterial contaminants and infection control implications. Infect Control.1985;6 :194\u2013 199","DOI":"10.1017\/S0195941700061415"},{"key":"2021121006381515900_R169","doi-asserted-by":"crossref","unstructured":"Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control.2001;29 :312\u2013 315","DOI":"10.1067\/mic.2001.117043"},{"key":"2021121006381515900_R170","doi-asserted-by":"crossref","unstructured":"Grohskopf LA, Roth VR, Feikin DR, et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med.2001;344 :1491\u2013 1497","DOI":"10.1056\/NEJM200105173442001"},{"key":"2021121006381515900_R171","doi-asserted-by":"crossref","unstructured":"CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from April 1995\u2013April 2000, issued June 2000. Am J Infect Control.2000;28 :429\u2013 435","DOI":"10.1067\/mic.2000.110544"},{"key":"2021121006381515900_R172","doi-asserted-by":"crossref","unstructured":"Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States: National Nosocomial Infections Surveillance System. Pediatrics.1999;103 :103\u2013 109","DOI":"10.1542\/peds.103.4.e39"},{"key":"2021121006381515900_R173","doi-asserted-by":"crossref","unstructured":"Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System. Crit Care Med.1999;27 :887\u2013 892","DOI":"10.1097\/00003246-199905000-00020"},{"key":"2021121006381515900_R174","doi-asserted-by":"crossref","unstructured":"Garland JS, Dunne WM Jr, Havens P, et al. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics.1992;89 :1145\u2013 1150","DOI":"10.1542\/peds.89.6.1145"},{"key":"2021121006381515900_R175","doi-asserted-by":"crossref","unstructured":"Garland JS, Nelson DB, Cheah TE, Hennes HH, Johnson TM. Infectious complications during peripheral intravenous therapy with Teflon catheters: a prospective study. Pediatr Infect Dis J.1987;6 :918\u2013 921","DOI":"10.1097\/00006454-198710000-00012"},{"key":"2021121006381515900_R176","doi-asserted-by":"crossref","unstructured":"Furfaro S, Gauthier M, Lacroix J, Nadeau D, Lafleur L, Mathews S. Arterial catheter-related infections in children: a 1-year cohort analysis. Am J Dis Child.1991;145 :1037\u2013 1043","DOI":"10.1001\/archpedi.1991.02160090089031"},{"key":"2021121006381515900_R177","doi-asserted-by":"crossref","unstructured":"Krauss AN, Albert RF, Kannan MM. Contamination of umbilical catheters in the newborn infant. J Pediatr.1970;77 :965\u2013 969","DOI":"10.1016\/S0022-3476(70)80078-6"},{"key":"2021121006381515900_R178","doi-asserted-by":"crossref","unstructured":"Landers S, Moise AA, Fraley JK, Smith EO, Baker CJ. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child.1991;145 :675\u2013 680","DOI":"10.1001\/archpedi.1991.02160060093028"},{"key":"2021121006381515900_R179","doi-asserted-by":"crossref","unstructured":"Balagtas RC, Bell CE, Edwards LD, Levin S. Risk of local and systemic infections associated with umbilical vein catheterization: a prospective study in 86 newborn patients. Pediatrics.1971;48 :359\u2013 367","DOI":"10.1542\/peds.48.3.359"},{"key":"2021121006381515900_R180","doi-asserted-by":"crossref","unstructured":"Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous central venous catheterization in a pediatric intensive care unit: a survival analysis of complications. Crit Care Med.1989;17 :984\u2013 988","DOI":"10.1097\/00003246-198910000-00003"},{"key":"2021121006381515900_R181","doi-asserted-by":"crossref","unstructured":"Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics.2001;107 :1431\u2013 1436","DOI":"10.1542\/peds.107.6.1431"},{"key":"2021121006381515900_R182","doi-asserted-by":"crossref","unstructured":"Davis D, O\u2019Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA.1999;282 :867\u2013 874","DOI":"10.1001\/jama.282.9.867"},{"key":"2021121006381515900_R183","doi-asserted-by":"crossref","unstructured":"Conly JM, Hill S, Ross J, Lertzman J, Louie TJ. Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates. Am J Infect Control.1989;17 :330\u2013 339","DOI":"10.1016\/0196-6553(89)90002-3"},{"key":"2021121006381515900_R184","unstructured":"East SA. Planning, implementation, and evaluation of a successful hospital-based peripherally inserted central catheter program. J Intraven Nurs.1994;17 :189\u2013 192"},{"key":"2021121006381515900_R185","unstructured":"Kyle KS, Myers JS. Peripherally inserted central catheters. Development of a hospital-based program. J Intraven Nurs.1990;13 :287\u2013 290"},{"key":"2021121006381515900_R186","unstructured":"BeVier PA, Rice CE. Initiating a pediatric peripherally inserted central catheter and midline catheter program. J Intraven Nurs.1994;17 :201\u2013 205"},{"key":"2021121006381515900_R187","doi-asserted-by":"crossref","unstructured":"Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications: a prospective controlled study. Arch Intern Med.1984;144 :1191\u2013 1194","DOI":"10.1001\/archinte.144.6.1191"},{"key":"2021121006381515900_R188","doi-asserted-by":"crossref","unstructured":"Wenzel RP, Wentzel RP. The development of academic programs for quality assessment. Arch Intern Med.1991;151 :653\u2013 654","DOI":"10.1001\/archinte.151.4.653"},{"key":"2021121006381515900_R189","doi-asserted-by":"crossref","unstructured":"Robert J, Fridkin SK, Blumberg HM, et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol.2000;21 :12\u2013 17","DOI":"10.1086\/501690"},{"key":"2021121006381515900_R190","doi-asserted-by":"crossref","unstructured":"Vicca AF. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect.1999;43 :109\u2013 113","DOI":"10.1053\/jhin.1999.0246"},{"key":"2021121006381515900_R191","doi-asserted-by":"crossref","unstructured":"White MC, Ragland KE. Surveillance of intravenous catheter-related infections among home care clients. Am J Infect Control.1994;22 :231\u2013 235","DOI":"10.1016\/0196-6553(94)99002-6"},{"key":"2021121006381515900_R192","doi-asserted-by":"crossref","unstructured":"Lorenzen AN, Itkin DJ. Surveillance of infection in home care. Am J Infect Control.1992;20 :326\u2013 329","DOI":"10.1016\/S0196-6553(05)80238-X"},{"key":"2021121006381515900_R193","doi-asserted-by":"crossref","unstructured":"White MC. Infections and infection risks in home care settings. Infect Control Hosp Epidemiol.1992;13 :535\u2013 539","DOI":"10.1086\/646593"},{"key":"2021121006381515900_R194","doi-asserted-by":"crossref","unstructured":"Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis.1995;20 :593\u2013 597","DOI":"10.1093\/clinids\/20.3.593"},{"key":"2021121006381515900_R195","doi-asserted-by":"crossref","unstructured":"Widmer AF, Nettleman M, Flint K, Wenzel RP. The clinical impact of culturing central venous catheters: a prospective study. Arch Intern Med.1992;152 :1299\u2013 1302","DOI":"10.1001\/archinte.152.6.1299"},{"key":"2021121006381515900_R196","unstructured":"Boyce JM, Farr BM, Jarvis WR, et al. Guideline for hand hygiene in the healthcare setting. Am J Infect Control.2002. In press"},{"key":"2021121006381515900_R197","doi-asserted-by":"crossref","unstructured":"Bischoff WE, Reynolds TM, Sessler CN, Edmond MB, Wenzel RP. Handwashing compliance by health care workers: the impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med.2000;160 :1017\u2013 1021","DOI":"10.1001\/archinte.160.7.1017"},{"key":"2021121006381515900_R198","doi-asserted-by":"crossref","unstructured":"Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med.1999;159 :821\u2013 826","DOI":"10.1001\/archinte.159.8.821"},{"key":"2021121006381515900_R199","doi-asserted-by":"crossref","unstructured":"Simmons B, Bryant J, Neiman K, Spencer L, Arheart K. The role of handwashing in prevention of endemic intensive care unit infections. Infect Control Hosp Epidemiol.1990;11 :589\u2013 594","DOI":"10.1086\/646100"},{"key":"2021121006381515900_R200","doi-asserted-by":"crossref","unstructured":"Boyce JM, Kelliher S, Vallande N. Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol.2000;21 :442\u2013 448","DOI":"10.1086\/501785"},{"key":"2021121006381515900_R201","doi-asserted-by":"crossref","unstructured":"Capdevila JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis.1998;2 :230\u2013 236","DOI":"10.1016\/S1201-9712(98)90059-5"},{"key":"2021121006381515900_R202","doi-asserted-by":"crossref","unstructured":"Abi-Said D, Raad II, Umphrey J, Gonzalez V, Richardson D, Marts K, Hohn D. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol.1999;20 :101\u2013 105","DOI":"10.1086\/501597"},{"key":"2021121006381515900_R203","unstructured":"CDC. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep.1988;37 :377\u2013 382, 388"},{"key":"2021121006381515900_R204","doi-asserted-by":"crossref","unstructured":"Povoski SP. A prospective analysis of the cephalic vein cutdown approach for chronic indwelling central venous access in 100 consecutive cancer patients. Ann Surg Oncol.2000;7 :496\u2013 502","DOI":"10.1007\/s10434-000-0496-9"},{"key":"2021121006381515900_R205","doi-asserted-by":"crossref","unstructured":"Arrighi DA, Farnell MB, Mucha P Jr, Iistrup DM, Anderson DL. Prospective, randomized trial of rapid venous access for patients in hypovolemic shock. Ann Emerg Med.1989;18 :927\u2013 930","DOI":"10.1016\/S0196-0644(89)80454-8"},{"key":"2021121006381515900_R206","doi-asserted-by":"crossref","unstructured":"Ahmed Z, Mohyuddin Z. Complications associated with different insertion techniques for Hickman catheters. Postgrad Med J.1998;74 :104\u2013 107","DOI":"10.1136\/pgmj.74.868.104"},{"key":"2021121006381515900_R207","doi-asserted-by":"crossref","unstructured":"Little JR, Murray PR, Traynor PS, Spitznagel E. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med.1999;107 :119\u2013 125","DOI":"10.1016\/S0002-9343(99)00197-7"},{"key":"2021121006381515900_R208","doi-asserted-by":"crossref","unstructured":"Mimoz O, Pieroni L, Lawrence C, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med.1996;24 :1818\u2013 1823","DOI":"10.1097\/00003246-199611000-00010"},{"key":"2021121006381515900_R209","doi-asserted-by":"crossref","unstructured":"Maki DG, McCormack KN. Defatting catheter insertion sites in total parenteral nutrition is of no value as an infection control measure. Controlled clinical trial. Am J Med.1987;83 :833\u2013 840","DOI":"10.1016\/0002-9343(87)90639-5"},{"key":"2021121006381515900_R210","doi-asserted-by":"crossref","unstructured":"Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol.1999;20 :618\u2013 620","DOI":"10.1086\/501682"},{"key":"2021121006381515900_R211","unstructured":"Rasero L, Degl\u2019Innocenti M, Mocali M, et al. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. Haematologica.2000;85 :275\u2013 279"},{"key":"2021121006381515900_R212","doi-asserted-by":"crossref","unstructured":"Madeo M, Martin CR, Turner C, Kirkby V, Thompson DR. A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive Crit Care Nurs.1998;14 :187\u2013 191","DOI":"10.1016\/S0964-3397(98)80512-0"},{"key":"2021121006381515900_R213","doi-asserted-by":"crossref","unstructured":"Flowers RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: a randomized, controlled trial. JAMA.1989;261 :878\u2013 883","DOI":"10.1001\/jama.261.6.878"},{"key":"2021121006381515900_R214","doi-asserted-by":"crossref","unstructured":"Robbins J, Cromwell P, Korones DN. Swimming and central venous catheter-related infections in the child with cancer. J Pediatr Oncol Nurs.1999;16 :51\u2013 56","DOI":"10.1177\/104345429901600107"},{"key":"2021121006381515900_R215","doi-asserted-by":"crossref","unstructured":"Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer.1995;75 :1367\u2013 1375","DOI":"10.1002\/1097-0142(19950315)75:6<1367::AID-CNCR2820750620>3.0.CO;2-Z"},{"key":"2021121006381515900_R216","unstructured":"Goetz AM, Miller J, Wagener MM, Muder RR. Complications related to intravenous midline catheter usage: a 2-year study. J Intraven Nurs.1998;21 :76\u2013 80"},{"key":"2021121006381515900_R217","doi-asserted-by":"crossref","unstructured":"Martin C, Viviand X, Saux P, Gouin F. Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med.1999;27 :2626\u2013 2629","DOI":"10.1097\/00003246-199912000-00004"},{"key":"2021121006381515900_R218","doi-asserted-by":"crossref","unstructured":"Robinson JF, Robinson WA, Cohn A, Garg K, Armstrong JD. Perforation of the great vessels during central venous line placement. Arch Intern Med.1995;155 :1225\u2013 1228","DOI":"10.1001\/archinte.155.11.1225"},{"key":"2021121006381515900_R219","doi-asserted-by":"crossref","unstructured":"Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter. Ann Intern Med.1992;116 :737\u2013 738","DOI":"10.7326\/0003-4819-116-9-737"},{"key":"2021121006381515900_R220","doi-asserted-by":"crossref","unstructured":"Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intravenous catheter use: internal medicine house staff participate in a successful quality improvement project. Arch Intern Med.1994;154 :1829\u2013 1832","DOI":"10.1001\/archinte.154.16.1829"},{"key":"2021121006381515900_R221","doi-asserted-by":"crossref","unstructured":"Thomas F, Burke JP, Parker J, et al. The risk of infection related to radial vs femoral sites for arterial catheterization. Crit Care Med.1983;11 :807\u2013 812","DOI":"10.1097\/00003246-198310000-00009"},{"key":"2021121006381515900_R222","doi-asserted-by":"crossref","unstructured":"Nelson DB, Garland JS. The natural history of Teflon catheter-associated phlebitis in children. Am J Dis Child.1987;141 :1090\u2013 1092","DOI":"10.1001\/archpedi.1987.04460100068028"},{"key":"2021121006381515900_R223","doi-asserted-by":"crossref","unstructured":"Shimandle RB, Johnson D, Baker M, Stotland N, Karrison T, Arnow PM. Safety of peripheral intravenous catheters in children. Infect Control Hosp Epidemiol.1999;20 :736\u2013 740","DOI":"10.1086\/501574"},{"key":"2021121006381515900_R224","doi-asserted-by":"crossref","unstructured":"O\u2019Grady NP, Barie PS, Bartlett J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med.1998;26 :392\u2013 408","DOI":"10.1097\/00003246-199802000-00046"},{"key":"2021121006381515900_R225","doi-asserted-by":"crossref","unstructured":"Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis.2001;32 :1249\u2013 1272","DOI":"10.1086\/320001"},{"key":"2021121006381515900_R226","doi-asserted-by":"crossref","unstructured":"Mershon J, Nogami W, Williams JM, Yoder C, Eitzen HE, Lemons JA. Bacterial\/fungal growth in a combined parenteral nutrition solution. J Parenter Enteral Nutr.1986;10 :498\u2013 502","DOI":"10.1177\/0148607186010005498"},{"key":"2021121006381515900_R227","doi-asserted-by":"crossref","unstructured":"Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. J Parenter Enteral Nutr.1986;10 :494\u2013 497","DOI":"10.1177\/0148607186010005494"},{"key":"2021121006381515900_R228","doi-asserted-by":"crossref","unstructured":"Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis.1975;131 :267\u2013 272","DOI":"10.1093\/infdis\/131.3.267"},{"key":"2021121006381515900_R229","doi-asserted-by":"crossref","unstructured":"Didier ME, Fischer S, Maki DG. Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: growth properties of microbial pathogens at room temperature. J Parenter Enteral Nutr.1998;22 :291\u2013 296","DOI":"10.1177\/0148607198022005291"},{"key":"2021121006381515900_R230","doi-asserted-by":"crossref","unstructured":"Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med.1995;333 :147\u2013 154","DOI":"10.1056\/NEJM199507203330303"},{"key":"2021121006381515900_R231","doi-asserted-by":"crossref","unstructured":"Roth VR, Arduino MJ, Nobiletti J, et al. Transfusion-related sepsis due to Serratia liquefaciens in the United States. Transfusion.2000;40 :931\u2013 935","DOI":"10.1046\/j.1537-2995.2000.40080931.x"},{"key":"2021121006381515900_R232","unstructured":"Blajchman MA. Reducing the risk of bacterial contamination of cellular blood components. Dev Biol Stand.2000;102 :183\u2013 193"},{"key":"2021121006381515900_R233","doi-asserted-by":"crossref","unstructured":"Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion.1993;33 :228\u2013 233","DOI":"10.1046\/j.1537-2995.1993.33393174449.x"},{"key":"2021121006381515900_R234","doi-asserted-by":"crossref","unstructured":"Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev.1994;7 :290\u2013 302","DOI":"10.1128\/CMR.7.3.290"},{"key":"2021121006381515900_R235","doi-asserted-by":"crossref","unstructured":"Plott RT, Wagner RF Jr, Tyring SK. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol.1990;126 :1441\u2013 1444","DOI":"10.1001\/archderm.126.11.1441"},{"key":"2021121006381515900_R236","doi-asserted-by":"crossref","unstructured":"Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol.1993;31 :475\u2013 479","DOI":"10.1128\/jcm.31.3.475-479.1993"},{"key":"2021121006381515900_R237","doi-asserted-by":"crossref","unstructured":"ASHP Council on Professional Affairs. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health Syst Pharm.2000;57 :1150\u2013 1169","DOI":"10.1093\/ajhp\/57.12.1150"},{"key":"2021121006381515900_R238","doi-asserted-by":"crossref","unstructured":"Herruzo-Cabrera R, Garcia-Caballero J, Vera-Cortes ML, et al. Growth of microorganisms in parenteral nutrient solutions. Am J Hosp Pharm.1984;41 :1178\u2013 1180","DOI":"10.1093\/ajhp\/41.6.1178"},{"key":"2021121006381515900_R239","doi-asserted-by":"crossref","unstructured":"Green KA, Shouldachi B, Schoer K, Moro D, Blend R, McGeer A. Gadolinium-based MR contrast media: potential for growth of microbial contaminants when single vials are used for multiple patients. AJR Am J Roentgenol.1995;165 :669\u2013 671","DOI":"10.2214\/ajr.165.3.7645493"},{"key":"2021121006381515900_R240","unstructured":"Arrington ME, Gabbert KC, Mazgaj PW, Wolf MT. Multidose vial contamination in anesthesia. AANA J.1990;58 :462\u2013 466"},{"key":"2021121006381515900_R241","doi-asserted-by":"crossref","unstructured":"Falchuk KH, Peterson L, McNeil BJ. Microparticulate-induced phlebitis: its prevention by in-line filtration. N Engl J Med.1985;312 :78\u2013 82","DOI":"10.1056\/NEJM198501103120203"},{"key":"2021121006381515900_R242","doi-asserted-by":"crossref","unstructured":"Cohran J, Larson E, Roach H, Blane C, Pierce P. Effect of intravascular surveillance and education program on rates of nosocomial bloodstream infections. Heart Lung.1996;25 :161\u2013 164","DOI":"10.1016\/S0147-9563(96)80120-8"},{"key":"2021121006381515900_R243","doi-asserted-by":"crossref","unstructured":"Netto dos Santos KR, de Souza Fonseca L, Gontijo Filho PP. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol.1996;17 :813\u2013 816","DOI":"10.1086\/647243"},{"key":"2021121006381515900_R244","doi-asserted-by":"crossref","unstructured":"Ryder MA. Peripheral access options. Surg Oncol Clin North Am.1995;4 :395\u2013 427","DOI":"10.1016\/S1055-3207(18)30434-4"},{"key":"2021121006381515900_R245","doi-asserted-by":"crossref","unstructured":"Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med.1973;79 :867\u2013 887","DOI":"10.7326\/0003-4819-79-6-867"},{"key":"2021121006381515900_R246","doi-asserted-by":"crossref","unstructured":"Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol.1983;118 :839\u2013 851","DOI":"10.1093\/oxfordjournals.aje.a113702"},{"key":"2021121006381515900_R247","doi-asserted-by":"crossref","unstructured":"Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am J Infect Control.1997;25 :112\u2013 116","DOI":"10.1016\/S0196-6553(97)90037-7"},{"key":"2021121006381515900_R248","doi-asserted-by":"crossref","unstructured":"Khuri-Bulos NA, Shennak M, Agabi S, et al. Nosocomial infections in the intensive care units at a university hospital in a developing country: comparison with National Nosocomial Infections Surveillance intensive care unit rates. Am J Infect Control.1999;27 :547\u2013 552","DOI":"10.1016\/S0196-6553(99)70035-0"},{"key":"2021121006381515900_R249","doi-asserted-by":"crossref","unstructured":"Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med.1995;155 :1177\u2013 1184","DOI":"10.1001\/archinte.155.11.1177"},{"key":"2021121006381515900_R250","unstructured":"CDC. Monitoring hospital-acquired infections to promote patient safety\u2014United States, 1990\u20131999. MMWR Morb Mortal Wkly Rep.2000;49 :149\u2013 153"},{"key":"2021121006381515900_R251","doi-asserted-by":"crossref","unstructured":"Clark-Christoff N, Watters VA, Sparks W, Snyder P, Grant JP. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. J Parenter Enteral Nutr.1992;16 :403\u2013 407","DOI":"10.1177\/0148607192016005403"},{"key":"2021121006381515900_R252","doi-asserted-by":"crossref","unstructured":"Early TF, Gregory RT, Wheeler JR, Snyder SO Jr, Gayle RG. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J.1990;83 :34\u2013 36","DOI":"10.1097\/00007611-199001000-00010"},{"key":"2021121006381515900_R253","doi-asserted-by":"crossref","unstructured":"Hilton E, Haslett TM, Borenstein MT, Tucci V, Isenberg HD, Singer C. Central catheter infections: single- versus triple-lumen catheters: influence of guide wires on infection rates when used for replacement of catheters. Am J Med.1988;84 :667\u2013 672","DOI":"10.1016\/0002-9343(88)90102-7"},{"key":"2021121006381515900_R254","doi-asserted-by":"crossref","unstructured":"Yeung C, May J, Hughes R. Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol.1988;9 :154\u2013 158","DOI":"10.1086\/645820"},{"key":"2021121006381515900_R255","doi-asserted-by":"crossref","unstructured":"Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest.1999;115 :1632\u2013 1640","DOI":"10.1378\/chest.115.6.1632"},{"key":"2021121006381515900_R256","doi-asserted-by":"crossref","unstructured":"Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med.1993;119 :1168\u2013 1174","DOI":"10.7326\/0003-4819-119-12-199312150-00003"},{"key":"2021121006381515900_R257","doi-asserted-by":"crossref","unstructured":"Pegues D, Axelrod P, McClarren C, et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol.1992;49 :156\u2013 162","DOI":"10.1002\/jso.2930490306"},{"key":"2021121006381515900_R258","doi-asserted-by":"crossref","unstructured":"Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis.1990;16 :211\u2013 215","DOI":"10.1016\/S0272-6386(12)81020-1"},{"key":"2021121006381515900_R259","doi-asserted-by":"crossref","unstructured":"Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterization vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant.1991;6 :722\u2013 724","DOI":"10.1093\/ndt\/6.10.722"},{"key":"2021121006381515900_R260","doi-asserted-by":"crossref","unstructured":"Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron.1990;54 :154\u2013 161","DOI":"10.1159\/000185837"},{"key":"2021121006381515900_R261","doi-asserted-by":"crossref","unstructured":"Barrett N, Spencer S, McIvor J, Brown EA. Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol Dial Transplant.1988;3 :423\u2013 425","DOI":"10.1093\/oxfordjournals.ndt.a091691"},{"key":"2021121006381515900_R262","doi-asserted-by":"crossref","unstructured":"Trerotola SO, Kuhn-Fulton J, Johnson MS, Shah H, Ambrosius WT, Kneebone PH. Tunneled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access. Radiology.2000;217 :89\u2013 93","DOI":"10.1148\/radiology.217.1.r00oc2789"},{"key":"2021121006381515900_R263","doi-asserted-by":"crossref","unstructured":"Macdonald S, Watt AJ, McNally D, Edwards RD, Moss JG. Comparison of technical success and outcome of tunneled catheters inserted via the jugular and subclavian approaches. J Vasc Interv Radiol.2000;11 :225\u2013 231","DOI":"10.1016\/S1051-0443(07)61470-5"},{"key":"2021121006381515900_R264","doi-asserted-by":"crossref","unstructured":"Widmer AF. Management of catheter-related bacteremia and fungemia in patients on total parenteral nutrition. Nutrition.1997;13(suppl) :S18\u2013 S25","DOI":"10.1016\/S0899-9007(97)00218-9"},{"key":"2021121006381515900_R265","doi-asserted-by":"crossref","unstructured":"Powell C, Kudsk KA, Kulich PA, Mandelbaum JA, Fabri PJ. Effect of frequent guidewire changes on triple-lumen catheter sepsis. J Parenter Enteral Nutr.1988;12 :462\u2013 464","DOI":"10.1177\/0148607188012005462"},{"key":"2021121006381515900_R266","doi-asserted-by":"crossref","unstructured":"Snydman DR, Murray SA, Kornfeld SJ, Majka JA, Ellis CA. Total parenteral nutrition-related infections: prospective epidemiologic study using semiquantitative methods. Am J Med.1982;73 :695\u2013 699","DOI":"10.1016\/0002-9343(82)90412-0"},{"key":"2021121006381515900_R267","unstructured":"Easom A. Prophylactic antibiotic lock therapy for hemodialysis catheters. Nephrol Nurs J.2000;27 :75"},{"key":"2021121006381515900_R268","doi-asserted-by":"crossref","unstructured":"Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy.2000;20 :394\u2013 399","DOI":"10.1592\/phco.20.5.394.35063"},{"key":"2021121006381515900_R269","doi-asserted-by":"crossref","unstructured":"Donowitz LG, Marsik FJ, Hoyt JW, Wenzel RP. Serratia marcescens bacteremia from contaminated pressure transducers. JAMA.1979;242 :1749\u2013 1751","DOI":"10.1001\/jama.242.16.1749"},{"key":"2021121006381515900_R270","doi-asserted-by":"crossref","unstructured":"Luskin RL, Weinstein RA, Nathan C, Chamberlin WH, Kabins SA. Extended use of disposable pressure transducers: a bacteriologic evaluation. JAMA.1986;255 :916\u2013 920","DOI":"10.1001\/jama.255.7.916"},{"key":"2021121006381515900_R271","doi-asserted-by":"crossref","unstructured":"Maki DG, Hassemer CA. Endemic rate of fluid contamination and related septicemia in arterial pressure monitoring. Am J Med.1981;70 :733\u2013 738","DOI":"10.1016\/0002-9343(81)90604-5"},{"key":"2021121006381515900_R272","doi-asserted-by":"crossref","unstructured":"Mermel LA, Maki DG. Epidemic bloodstream infections from hemodynamic pressure monitoring: signs of the times. Infect Control Hosp Epidemiol.1989;10 :47\u2013 53","DOI":"10.1086\/645960"},{"key":"2021121006381515900_R273","doi-asserted-by":"crossref","unstructured":"Tenold R, Priano L, Kim K, Rourke B, Marrone T. Infection potential of nondisposable pressure transducers prepared prior to use. Crit Care Med.1987;15 :582\u2013 583","DOI":"10.1097\/00003246-198706000-00007"},{"key":"2021121006381515900_R274","doi-asserted-by":"crossref","unstructured":"Leroy O, Billiau V, Beuscart C, et al. Nosocomial infections associated with long-term radial artery cannulation. Intensive Care Med.1989;15 :241\u2013 246","DOI":"10.1007\/BF00271059"},{"key":"2021121006381515900_R275","doi-asserted-by":"crossref","unstructured":"Fisher MC, Long SS, Roberts EM, Dunn JM, Balsara RK. Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA.1981;246 :1571\u2013 1574","DOI":"10.1001\/jama.246.14.1571"},{"key":"2021121006381515900_R276","doi-asserted-by":"crossref","unstructured":"Stamm WE, Colella JJ, Anderson RL, Dixon RE. Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species. N Engl J Med.1975;292 :1099\u2013 1102","DOI":"10.1056\/NEJM197505222922105"},{"key":"2021121006381515900_R277","doi-asserted-by":"crossref","unstructured":"Weinstein RA, Emori TG, Anderson RL, Stamm WE. Pressure transducers as a source of bacteremia after open heart surgery: report of an outbreak and guidelines for prevention. Chest.1976;69 :338\u2013 344","DOI":"10.1378\/chest.69.3.338"},{"key":"2021121006381515900_R278","doi-asserted-by":"crossref","unstructured":"Shinozaki T, Deane RS, Mazuzan JE Jr, Hamel AJ, Hazelton D. Bacterial contamination of arterial lines: a prospective study. JAMA.1983;249 :223\u2013 225","DOI":"10.1001\/jama.249.2.223"},{"key":"2021121006381515900_R279","doi-asserted-by":"crossref","unstructured":"Solomon SL, Alexander H, Eley JW, et al. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis.1986;5 :680\u2013 685","DOI":"10.1097\/00006454-198611000-00016"},{"key":"2021121006381515900_R280","doi-asserted-by":"crossref","unstructured":"Weems JJ Jr, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol.1987;25 :1029\u2013 1032","DOI":"10.1128\/jcm.25.6.1029-1032.1987"},{"key":"2021121006381515900_R281","doi-asserted-by":"crossref","unstructured":"Beck-Sague CM, Jarvis WR, Brook JH, et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol.1990;132 :723\u2013 733","DOI":"10.1093\/oxfordjournals.aje.a115714"},{"key":"2021121006381515900_R282","doi-asserted-by":"crossref","unstructured":"Villarino ME, Jarvis WR, O\u2019Hara C, Bresnahan J, Clark N. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol.1989;27 :2433\u2013 2436","DOI":"10.1128\/jcm.27.11.2433-2436.1989"},{"key":"2021121006381515900_R283","doi-asserted-by":"crossref","unstructured":"Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health.1999;35 :460\u2013 465","DOI":"10.1046\/j.1440-1754.1999.355392.x"},{"key":"2021121006381515900_R284","doi-asserted-by":"crossref","unstructured":"Cronin WA, Germanson TP, Donowitz LG. Intravascular catheter colonization and related bloodstream infection in critically ill neonates. Infect Control Hosp Epidemiol.1990;11 :301\u2013 308","DOI":"10.1086\/646175"},{"key":"2021121006381515900_R285","doi-asserted-by":"crossref","unstructured":"Miller KL, Coen PE, White WJ, Hurst WJ, Achey BE, Lang CM. Effectiveness of skin absorption of tincture of I in blocking radioiodine from the human thyroid gland. Health Phys.1989;56 :911\u2013 914","DOI":"10.1097\/00004032-198906000-00009"},{"key":"2021121006381515900_R286","doi-asserted-by":"crossref","unstructured":"Ankola PA, Atakent YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol.1993;10 :229\u2013 232","DOI":"10.1055\/s-2007-994726"},{"key":"2021121006381515900_R287","doi-asserted-by":"crossref","unstructured":"Horgan MJ, Bartoletti A, Polansky S, Peters JC, Manning TJ, Lamont BM. Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications. J Pediatr.1987;111 :774\u2013 778","DOI":"10.1016\/S0022-3476(87)80266-4"},{"key":"2021121006381515900_R288","doi-asserted-by":"crossref","unstructured":"David RJ, Merten DF, Anderson JC, Gross S. Prevention of umbilical artery catheter clots with heparinized infusates. Dev Pharmacol Ther.1981;2 :117\u2013 126","DOI":"10.1159\/000481037"},{"key":"2021121006381515900_R289","doi-asserted-by":"crossref","unstructured":"Fletcher MA, Brown DR, Landers S, Seguin J. Umbilical arterial catheter use: report of an audit conducted by the Study Group for Complications of Perinatal Care. Am J Perinatol.1994;11 :94\u2013 99","DOI":"10.1055\/s-2007-994564"},{"key":"2021121006381515900_R290","doi-asserted-by":"crossref","unstructured":"Seguin J, Fletcher MA, Landers S, Brown D, Macpherson T. Umbilical venous catheterizations: audit by the Study Group for Complications of Perinatal Care. Am J Perinatol.1994;11 :67\u2013 70","DOI":"10.1055\/s-2007-994540"},{"key":"2021121006381515900_R291","unstructured":"Loisel DB, Smith MM, MacDonald MG, Martin GR. Intravenous access in newborn infants: impact of extended umbilical venous catheter use on requirement for peripheral venous lines. J Perinatol.1996;16 :461\u2013 466"},{"key":"2021121006381515900_R292","doi-asserted-by":"crossref","unstructured":"Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control.1988;16 :128\u2013 140","DOI":"10.1016\/0196-6553(88)90053-3"},{"key":"2021121006381515900_R293","doi-asserted-by":"crossref","unstructured":"Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988 [erratum]. Am J Infect Control.1988;16 :177","DOI":"10.1016\/0196-6553(88)90053-3"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/5\/e51\/1116943\/pe11020000g1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/5\/e51\/1116943\/pe11020000g1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:33:22Z","timestamp":1682746402000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/110\/5\/e51\/64492\/Guidelines-for-the-Prevention-of-Intravascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":293,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2002,11,1]]},"published-print":{"date-parts":[[2002,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.110.5.e51","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}